https://harvard2thebighouse.substack.com/p/china-owns-nature-magazines-ass

China owns Nature Magazine’s ass

Debunking claims from the article “The proximal origin of SARS-CoV-2” arguing that COVID-19 definitely wasn’t engineered in a lab way back in March 2020

JUL 22, 2023

From the co-author of the first peer-reviewed paper examining a laboratory origin for SARS-CoV-2, as well as its addendum, which formally linked the H1N1 Spanish Flu pandemic strain release of 1977 to gain-of-function research.


Way back over three years ago when I’d only been looking into all this stuff for about six weeks, Nature Magazine published their much-ballyhooed The proximal origin of SARS-CoV-2 on March 17, 2020, which has since been cited by over 2,000 news outlets and been accessed nearly six-million times.

Just 48 hours later I’d respond with the article below, which thoroughly eviscerates the idiotic assertions put forth by that article, none of which hold up to even the slightest bit of logical or scientific scrutiny. This article was transparent propaganda from the very start, and yet it’s gone nearly untouched in the press and the academic literature, as the only thing that’s allowed to the surface is the limited hangouts pretending to argue about technical minutiae from over two years ago.

If a scientific outsider and untrained journalist was able to almost instantly point all of this out over three years ago after he’d just been studying all this stuff for a few weeks, to zero in on serial passage as a vital part of the puzzle and tear apart the façade presented by Kristian Andersen, how come the rest of the media – making their six-figure salaries and getting all their fancy awards – has gone along with their charade and is still suppressing the two peer-reviewed papers linked above?

Because after three years, the media and our governments are still determined to pour poison into your ears, since the billionaires who own them all aren’t ever going to admit their roll in the worst crime against humanity in our shared history.  (See link for article)

_________________

Important quote:

Nature magazine has censored over 1,000 articles at the request of the Chinese government over the past several years, and runs columns sponsored by outside interests. And it seems pretty clear that their recent article, “The proximal origin of SARS-CoV-2” is just one more example of their influence. China bought off the head of Harvard’s chemistry department, you don’t think they could buy off run-of-the-mill research scientists scrambling for tenure and funding and publication?

Please also read the same author’s article, “Golden Silkworms in Pandora’s Box” that explains what happens when dangerous and unproven scientific research techniques meet the military-industrial complex.  Important Quote:

“Answering these questions will reveal the ties that bind together the histories of mysterious military illnesses, the emergence of HIV, the source of the 1918 Spanish Flu Pandemic, anal swabs, COVID-19’s origins, Original Antigenic Sin, both the SARS and MERS Outbreaks, the 2009 Swine Flu Pandemic, as well as experimental but profitable vaccination protocols – all to the fates of those who would put fame and fortune over human life and academic ethics.”

________________

https://www.theblaze.com/news/deborah-birx-pharmaceutical-company-armata

Former White House Coronavirus Task Force advisor Deborah Birx named CEO of pharmaceutical company, has been active in private sector since leaving government positions

NEWS

Deborah Birx – the former White House Coronavirus Task Force coordinator under former President Donald Trump – has been named as the CEO of a pharmaceutical company.

Excerpt:

The California-based pharmaceutical company said it is currently “developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens.”

  • In March 2021, Birx joined the board of directors at Innoviva – a self-described “diversified holding company with a portfolio of royalties that include respiratory assets partnered with Glaxo Group Limited (GSK), as well as a growing portfolio of innovative healthcare investments and assets in areas of significant unmet medical need.”
  • Also in March 2021, Birx became a “Medical and Science Advisor” at ActivePure – a technology company with a self-described “commitment to creating the purest indoor space possible.”
  • In September 2022, Birx joined the board of directors for Nanolive – a Swiss microscope company that claims to provide “breakthrough imaging and analysis solutions that accelerate research in growth industries such as drug discovery and cell therapy.”
  • In October 2022, Birx was named a member of the Federal Advisory Board for Palantir – a software company specializing in data analytics and data integration. TechCrunch previously reported, “As of 2013, Palantir was used by at least 12 groups within the US Government including the CIA, DHS, NSA, FBI, the CDC, the Marine Corps, the Air Force, Special Operations Command, West Point, the Joint IED-defeat organization and Allies, the Recovery Accountability and Transparency Board and the National Center for Missing and Exploited Children.”

_________________

For more:

Join our Twitter Space event this Saturday at 4pm UTC to hear real stories from real people that have successfully utilized Ivermectin!

Featuring: 🇬🇧 Dr Tess Lawrie, 🇿🇦 Shabnam Palesa Mohamed, 🇺🇸 Dr Pierre Kory, 🇨🇦 Dr Chris Shoemaker, 🇬🇧 Edmund Fordham, PhD, 🇿🇦 Terry Herholdt, 🇬🇧 Dr Tina Peers, 🇿🇦 Dr Shankara Chetty, 🇿🇼 Dr Jackie Stone, 🇮🇳 Dr Amitav Banerjee, 🇮🇳 Dr Lenny Da Costa, and many more!

Can’t make the live meeting? Don’t worry! You can find it in the Newsroom after the meeting or in the Video Library later this week.

Mind Health Meditation with Cameron Tukapua

Join us on Telegram this Wednesday for another guided meditation led by Cameron Tukapua.
After 10 years of acupuncture practice, Cameron was invited to teach at a Wellbeing retreat centre in Hawaii. She then started an Acupuncture College in Christchurch, New Zealand and also co-leads Wellbeing, Qigong, and Yoga retreats in China. Spreading holistic worldviews is the natural extension of her practice.

BWC Workshop with Dr Marik & Dr Myhill Now Available!

In this exclusive workshop, Dr Paul Marik and Dr Sarah Myhill share their extensive knowledge of what people can do to help recover from spike-induced vaccine injury.

Watch or share this important workshop now.

General Assembly Meeting #96 Now Available

General Assembly Meeting #96

On July 17, 2023, we heard from Cambel McLaughlin, Rev Dr Wai-Ching Lee, and Shabnam Palesa Mohamed at World Council for Health General Assembly Meeting #96.

Upcoming Events

General Assembly Meeting #97

Monday 24 July

Join us in the WCH Newsroom.

Mind Health Meditation

Wednesday 26 July

Join Cameron Tukapua on Telegram.

World Ivermectin Day 2023

Saturday 29 July

Learn more at WorldIvermectinDay.org.

Join our Twitter Space here.

Emerging Post Pandemic Diseases

29-30 August

Jam For Freedom Festival

An International Celebration of Music, Art and Life

3-6 August

Harlow, Essex

Learn more here. Jam for Freedom is now SOLD OUT.

Campout 2023

An International Celebration of Music, Art and Life

10-13 August

Oxfordshire, UK

Learn more and purchase tickets here.

MAAFIM International Conference

An International Celebration of Music, Art and Life

14-17 September

Kuala Lumpur, Malaysia

Learn more and purchase tickets here.

Click Here to Support the World Council for Health

If you found the information in this email valuable, please take a moment to forward it to a friend!

https://www.cureus.com/articles/163816-tick-borne-myopericarditis-with-positive-anaplasma-lyme-and-epstein-barr-virus-ebv-serology-a-case-report#!/

Tick-Borne Myopericarditis With Positive Anaplasma, Lyme, and Epstein Barr Virus (EBV) Serology: A Case Report

Hassaan Arshad • Bashar Oudah • Aliaa Mousa • Tigran Kakhktsyan • Mohammad Abu-Abaa • Ashish Agarwal

Published: June 14, 2023

DOI: 10.7759/cureus.40440 

Peer-Reviewed

Cite this article as: Arshad H, Oudah B, Mousa A, et al. (June 14, 2023) Tick-Borne Myopericarditis With Positive Anaplasma, Lyme, and Epstein Barr Virus (EBV) Serology: A Case Report. Cureus 15(6): e40440. doi:10.7759/cureus.4044

Abstract

Myopericarditis has been reported only rarely in those with anaplasmosis and is typically difficult to diagnose. Lyme carditis can also be difficult to diagnose as it is relatively rare but potentially fatal and usually has nonspecific manifestations. We are presenting a 61-year-old male patient who presented in New Jersey, United States with unremitting fever, chills, and myalgia for two weeks along with nausea, vomiting, and diarrhea. Investigations were suggestive of perimyocarditis as was indicated by diffuse ST segment elevation on electrocardiography (EKG) with the presence of small pericardial effusion on echocardiography. A mild troponin leakage was also seen. This progressed to septic shock that required vasopressor therapy. Further history-taking revealed recent tick exposure and prompted empirical initiation of doxycycline. This proved to be successful with fever defervescence and clinical improvement. Serological tests confirmed both acute Lyme and anaplasma infections along with positive serology of Epstein Barr virus (EBV). This case highlights an uncommon presentation of carditis in acute Lyme and anaplasma infections with the associated false-positive serology of EBV. 

_________________

**Comment**

Again, not uncommon, just uncommonly reported.  How many cases must be reported before it is no longer rare?  It is also known in Lymeland that those with concurrent infections have more severe cases requiring longer treatment with many medications.

Yet sadly, the authors state:

“Both anaplasma and Lyme carditis usually have a good prognosis and can resolve spontaneously without intervention.”

Are you for real?

It’s statements like these that continue to undermine any forward progress as it supports an antiquated belief that these are simple nuisance illnesses that will go away on their own. Recent case studies have shown that chronically infected patients were helped with combo treatments given for a longer period of time.

Another glaring problem: not seeing a tick or rash. How many patients have similar presentations but because they don’t recall a tick bite they are misdiagnosed with something else?

For more:

https://www.lymedisease.org/remission-from-lyme-paralysis/

Paralyzed by Lyme, they were helped with combo treatments

By Lonnie Marcum

July 19, 2023

A new study from France looks at the use of combination antibiotics and anti-parasitic treatments in patients with limb paralysis as a result of tick-borne infections, including Lyme disease.

Approximately 70% of the patients in this study showed complete remission of symptoms after long-term treatment—a statistic that lines up with the MyLymeData treatment study.

The paper entitled, Complete Remission in Paralytic Late Tick-Borne Neurological Disease Comprising Mixed Involvement of Borrelia, Babesia, Anaplasma, and Bartonella: Use of Long-Term Treatments with Antibiotics and Antiparasitics in a Series of 10 Cases was published in Antibiotics.

The inclusion criteria for this study required a score of 4 or more on the Kurtzke EDSS disability scale; positive blood tests for one or more tick-borne pathogen (including Borrelia burgdorferi, Babesia, Anaplasma or Bartonella); and chronic general symptoms including fatigue, pain, and cognitive deficits lasting six or more months.

The Extended Disability Status Scale (EDSS) is a tool commonly used to quantify the level of disability in patients with multiple sclerosis. The EDSS grades six bodily functions, including visual, brain, bowel/bladder and sensory functions, as well as the patients’ ability to walk and take care of themselves.

All 10 of the patients that qualified for this study were severely disabled with partial or complete paralysis in at least one limb. Five of the 10 required a wheelchair for mobility, and four required assistive devices like walking sticks to get around.

Complete remission for 7 out of 10

Following extended treatment, seven out of 10 patients (70%) showed complete remission of symptoms. Among the nine patients with positive Borrelia serology (along with co-infections), 77% obtained complete remission.

The treatment administered varied according to the patient’s infection profile. The majority of the patients received repeated oral regimens of azithromycin-doxycycline and azithromycin-doxycycline-rifampin plus a minimum of three 35-day cycles of IV ceftriaxone. The eight patients co-infected with Babesia (a parasite) were also administered anti-parasitic cycles of atovaquone–azithromycin. The mean duration of treatment was 20 months +/- 6 months. (Trouillas 2023)

Historically, patients with late-stage Lyme disease have poor outcomes to single regimens of 10-day IV ceftriaxone. (I’ve previously written about brain inflammation, and small fiber neuropathy found in patients with continuing symptoms after short-term treatment for Lyme disease.)

And we have decades of strong evidence that under-treatment with single antibiotics is consistent with persistent infection in animal studies. (Embers 2012)

Two weeks isn’t enough

As far back as 1990, Dr. Allen Steere co-authored a paper on patients with persistent late-stage neurological Lyme disease.

In this paper Dr. Steere and his co-authors state:

Months to years after the initial infection with B. burgdorferi, patients with Lyme disease may have chronic encephalopathy, polyneuropathy, or less commonly, leukoencephalitis. These chronic neurologic abnormalities usually improve with antibiotic therapy.
…
Six months after a two-week course of intravenous ceftriaxone (2 g daily), 17 patients (63 percent) had improvement, 6 (22 percent) had improvement but then relapsed, and 4 (15 percent) had no change in their condition.
…
Six months after treatment, more than one third of the patients either had relapsed or were no better. In addition, more than half had previously received antibiotic therapy thought to be appropriate for their stage of disease and still had progression of the illness. The likely reason for relapse is failure to eradicate the spirochete completely with a two-week course of intravenous ceftriaxone therapy. (Logigian 1990)

MyLymeData

In fact, the MyLymeData study validates that longer antibiotic treatment durations are associated with moderate to a very great deal of improvement. (Johnson 2020)

MyLymeData is currently the largest observational study of patients using real-world data to analyze the response to treatment of chronic Lyme disease patients. The majority of patients (57%) reported treatment durations of four or more months,

The results of this new French study demonstrate the importance of clinicians being able to continue treatment until a patient’s symptoms have resolved. It is clear, at least in this study, that the presence of co-infections greatly compounds one’s disease progress and treatment options.

LymeSci is written by Lonnie Marcum, a Licensed Physical Therapist and mother of a daughter with Lyme. She served two terms on a subcommittee of the federal Tick-Borne Disease Working Group. Follow her on Twitter: @LonnieRhea  Email her at: lmarcum@lymedisease.org.

References

Embers ME, Barthold SW, Borda JT, Bowers L, Doyle L, Hodzic E, et al. Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection. PLoS ONE. 2012;7(1):e29914. Available at: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0029914.

 Johnson, L.; Shapiro, M.; Stricker, R.B.; Vendrow, J.; Haddock, J.; Needell, D. Antibiotic Treatment Response in Chronic Lyme Disease: Why Do Some Patients Improve While Others Do Not? Healthcare 2020, 8, 383. https://www.mdpi.com/2227-9032/8/4/383

Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990 Nov 22;323(21):1438-44. doi: 10.1056/NEJM199011223232102. PMID: 2172819.

Trouillas P, Franck M. Complete Remission in Paralytic Late Tick-Borne Neurological Disease Comprising Mixed Involvement of Borrelia, Babesia, Anaplasma, and Bartonella: Use of Long-Term Treatments with Antibiotics and Antiparasitics in a Series of 10 Cases. Antibiotics. 2023; 12(6):1021. https://doi.org/10.3390/antibiotics12061021

_________________

For more:

child suffering a seizure

A 2023 analysis published by researchers from Kaiser Permanente and the U.S. Centers for Disease Control and Prevention (CDC) in the journal Pediatrics compared vaccine adverse outcomes following administration of Pfizer/BioNTech’s Comirnaty messenger RNA (mRNA) COVID-19 shot and Moderna/NIAID’s Spikevax mRNA COVID-19 shot among recipients under five years old for a period of 1-21 days post-vaccination, compared to outcomes among those vaccinated 22-42 days post-vaccination. The authors reported that 104 children under the age of five suffered seizures after receiving an mRNA COVID shot.1

Although the study authors said that safety surveillance of more than 245,000 mRNA COVID shot doses over a period of nine months did not detect a safety signal for any outcome during the 21 days after vaccination, the data did show many adverse outcomes in absolute terms.2 3

Researchers leading the study used a process known as Rapid Cycle Analysis (RCA) to examine adverse vaccine outcomes of mRNA COVID shots on children under the age of five.4 RCA methods used in the CDC’s Vaccine Safety Datalink (VSD) were developed to conduct population-based monitoring of potential outcomes associated with a vaccine in near real-time by examining outcome rates in recent vaccine recipients during risk intervals in relation to rates during comparison intervals. Any associations between a vaccine and adverse outcomes produced by this approach are considered statistical signals that indicate the need for further investigation into the safety of a vaccine.5

The first period of 1-21 days, known as the “primary risk interval,” is believed to be the time-period that vaccinated people are more likely to experience adverse events. The period from 22-42 days is known as a comparison interval.6 Even though it is an assumption that adverse events that occur more than 21 days after vaccination are not associated with the vaccine received, according to William Schaffner, MD, a professor of preventative medicine at Vanderbilt University, said:

The idea for the events that occur in the latter period is that ‘it’s too late for them to be associated with a vaccine.’7

The analysis examined specific events that fit one or more of 23 specified outcomes, including seizures, myocarditis, appendicitis, Bell’s palsy, encephalitis, etc. following mRNA COVID shots.8

The analysis examined data available from June 18, 2022 to Mar. 18, 2023. 135,005 doses of Comirnaty were given to children six months to four years of age and 112,006 doses of Spikevax were given to children six months to five years of age in the VSD population.9

Study Finds Severe Adverse Outcomes in Children Following COVID Vaccination

One hundred and four children under six years of age suffered a seizure within 42 days of an mRNA COVID shot. In the first 21 days, 38 recipients of Comirnaty shots suffered seizures and 23 recipients of Spikevax shots experienced seizures. In the second period of 22-42 days following vaccination, 24 Comirnaty shot recipients suffered seizures and 19 Spikevax shot recipients experienced seizures.10

Appendicitis, Bell’s palsy, encephalitis, myelitis, or encephalomyelitis, Guillain-Barré syndrome (GBS), immune thrombocytopenia, Kawasaki disease, pulmonary embolism, hemorrhagic stroke, transverse myelitis and venous thromboembolism were detected in at least one child 1-42 days following mRNA COVID vaccination.11

Downplaying the significance of the serious immune and neurological disorders reported in children after mRNA COVID shots, Dr. Schaffner said:

We know that if you follow a half million children over the period of the year, some bad stuff is going to happen to some of those children.12

NVIC Calls For Vaccine Safety Studies by Independent Researchers

Barbara Loe Fisher, co-founder and president of the National Vaccine Information Center (NVIC), said that independent researchers should be conducting safety studies to compare outcomes from vaccinated and unvaccinated people. She stated:

The VSD is a government-maintained database that cannot be viewed by the public and is not easily accessible to independent researchers for oversight on or replication of study findings.13

Fisher added:

Where are the independent, methodologically sound COVID vaccine studies conducted by researchers who are not paid by government or industry that evaluate all morbidity and mortality outcomes in young children who do and do not receive mRNA COVID vaccines? That’s the study parents want to see done.

__________________

**Comment**

If you need an example of why studies can not be trusted at face-value, look no further.  To assume that a side effect that shows up on day 22 is somehow magically NOT caused by a vaccine demonstrates perfectly the insanity being touted as “science.”

Arbitrary cut-offs have been occurring in Lymeland for over 40 years and make no logical sense whatsoever, yet are accepted as science.